Forte Biosciences, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
FBRX on Nasdaq
Location
3060 Pegasus Park Drive, Building 6, Dallas, Texas

Insiders trading volume in the past year

Forte Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul A. Wagner CEO, Secretary and Chair of the Board, Director $1.26M +$75K +6.32% Jul 1, 2024
Antony A. Riley Chief Financial Officer $161K Jul 1, 2024
Hubert C. Chen President and Chief Scientific Officer $151K Jan 1, 2024
Steven Kornfeld Director Aug 20, 2024
Lawrence Eichenfield Director Aug 20, 2024
Barbara K. Finck Director Aug 20, 2024
Scott C. Brun Director Aug 20, 2024
Patricia S. Walker Director Jun 1, 2022
David W. Gryska Director Aug 20, 2024
Donald Allen Williams Director Aug 20, 2024
Stephen K. Doberstein Director Aug 20, 2024

Recent Insider Transactions by Companies or Individuals for Forte Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.